Skip to main content

Distinguished Lecture: Cultural Anthropology

The logo for The New York Academy of Sciences Anthropology Section.

April 8, 2024 | 6:00 PM – 8:30 PM ET

The U.S.-Mexico Border as Political Theater

Contemporary political rhetoric on immigration frequently uses metaphors of war: “crisis,” “invasions,” “enemies,” “under siege,” and “surveillance.” As metaphors, they may draw our attention to “something happening” in our world, but they can also be misleading, altering our perceptions and distorting our understanding of events. Metaphors of war can thus lead to questionable actions, such as those currently taking place at the U.S.-Mexico border.

In this talk I walk back contemporary political discourse to provide some historical context for the border as a source of political theater, which has consistently used photo ops and media spectacles to create a sense of “crisis.” For over fifty years now, according to political rhetoric, we have been in a near constant state of immigrant “invasions” and border “crisis.” The southern border is where the “battle” takes place in a “war on illegal immigration.” Over the last few decades, the U.S.-Mexico border has been likened to a “war zone,” with increasing levels of militarization and with, at various times, the National Guard and military personnel conducting surveillance, as well as David Duke’s “Klan Border Watch” in 1977 to the Minutemen and other militias “guarding” the border since the 1990s. More recently, the border has served as the backdrop for media spectacles, photo ops, and the politics of a border/immigration in “crisis” for many politicians, including Texas Governor Greg Abbott, Florida Governor Ron DeSantis, Vice President Kamala Harris, and President Biden.

As spectacles of surveillance, photo ops, walls made of shipping containers, giant buoys, barbed wire, and buses loaded with migrants, are public performances to sway public opinion on a “crisis” that has been part of public discourse for decades. Long after any particular politician’s political life waxes and wanes, these images will remain an indelible part of our nation’s history. Migrants were the subjects in these spectacles. They were used to generate media attention in a political struggle over immigration policy, while at the same time masking the humanitarian crisis at the border. If there is an “immigration crisis,” is not decades of Congressional inaction on immigration reform and political infighting partly to blame? Lacking from border spectacles are agreements about solutions, such as finding ways for millions of undocumented immigrants to regularize their status, preparing for the demographic realities that create a demand for immigrant labor, and providing a rational and humane asylum process. Rather, the theatrics of a border in “crisis” and immigrant “invasions” maintain the status quo, which is very productive and useful for some politicians.


Please join Academy President, Nicholas Dirks, together with invited speakers and board members of the Anthropology Section of The New York Academy of Sciences, for a discussion about the interfaces between anthropology, science, and society.  Historically at the heart of The Academy, prominent anthropologists from Franz Boas to Ruth Benedict and Margaret Mead, established both the core of American anthropology as a discipline and were early and pivotal leaders in The New York Academy of Sciences. Today, the Anthropology Section continues this tradition of engaged public scholarship, hosting an annual Distinguished Lecture Series as well as workshops and other events to bring New York and tri-state area anthropologists into regular, sustained conversations about social and cultural research and contemporary issues. We welcome your participation in this conversation, and your engagement with the Anthropology Section.  All voices are welcome!

Speakers

Speaker

Discussant

Professor Leo R. Chavez

Author, Covering Immigration: Popular Images and the Politics of the Nation & Shadowed Lives: Undocumented Immigrants in American Society 

Professor Alyshia Gálvez

CUNY’s Lehman College (Department of Latino and Puerto Rican Studies Department) and the Graduate Center (Department of Anthropology)

About the Series

Since 1877, the Anthropology Section of The New York Academy of Sciences has served as a meeting place for scholars in the Greater New York area. The section strives to be a progressive voice within the anthropological community and to contribute innovative perspectives on the human condition nationally and internationally. Learn more and view other events in the Anthropology Section series.

Discussion Groups

The logo for The New York Academy of Sciences.

Discussion Groups present half- and one-day symposia throughout the year in a given area, seeking to reflect the dynamism of scientific fields of relevance to our global community. Steering Committees composed of multi-institutional scientists from the Academy’s network shape each Discussion Group’s portfolio of events and publications, providing thought leadership on key issues of interest. Our Discussion Groups focus on the following scientific disciplines:

Biochemical Pharmacology Discussion Group

Understanding drug action at the frontiers of modern drug design

The Biochemical Pharmacology Discussion Group advances our fundamental knowledge of the activity and metabolism of both small molecules and biologics at the biochemical and molecular levels. Research spans chemotherapy, neuropharmacology, antimicrobials, inflammation, and immunopharmacology, as well as gastrointestinal, cardiovascular, and endocrine pharmacology and toxicology. The group also serves as the Biochemical Topical Group for the American Chemical Society‘s New York Chapter.

Biochemical Pharmacology Steering Committee Members

Scott Macdonnell, PhD, Regeneron

David Glass, MD, Regeneron

George Zavoico, PhD. Northwest Biotherapeutics

Megan Dow, PhD, Belenos Biosciences Inc.

Claire Steppan, PhD, Alexion Pharmaceuticals

Mercedes Beyna, MS, Garuda Therapeutics

Andrés Hurtado-Lorenzo PhD, Crohn’s & Colitis Foundation

Marco Prunotto, PhD, University of Geneva

Jim King, PhD, Boehringer Ingelheim 

Allison Lau. PhD, Lilly

Ignacio Juncadella, Arvinas

Brain and Behavior Discussion Group

Unlocking the secrets of the human brain

The Brain and Behavior Discussion Group advances fundamental knowledge about the brain and nervous system, providing the foundation for novel ways to reduce the burden of neurological disease.

Brain and Behavior Steering Committee Members

Howard Fillit, MD, Alzheimer’s Drug Discovery Foundation

Kevin Lee, PhD, The Lawrence Ellison Foundation; Grace Science Foundation

John Spiro, PhD, Simons Foundation

Gregory Petsko, D.Phil, Weill Cornell Medical College

Cancer Discussion Group

Advancing the world’s most promising research in cancer prevention, diagnosis, care, and cure

The Cancer Discussion Group advances fundamental knowledge of basic, translational, clinical, and diagnostic aspects in the field, with the goal of surfacing breakthroughs in cancer prevention, diagnosis, care and cure.

Cancer Steering Committee Members

Joan Massagué, PhD, Memorial Sloan Kettering Cancer Institute

Michael A. White, PhD, Pfizer

George Zavoico, PhD, Cue Biopharma

Chemical Biology Discussion Group

Chemical tools providing insight into biological function

Our portfolio of events and publications in Chemical Biology encompasses chemistry-based technology—such as proteomics, lipidomics, metabolomics, and glycomics—as well as synthetic and systems biology work when inspired and supported by chemical tools or aimed at engineering biological systems to perform a new type of chemical transformation. The Chemical Biology Discussion Group also serves as the Organic Topical Group for the American Chemical Society’s New York Chapter.

Chemical Biology Steering Committee Members

Paramjit Arora, PhD, New York University

Elizabeth Boon, PhD, Stony Brook University

Pamela V. Chang, PhD, Cornell University

David M. Chenoweth, PhD, University of Pennsylvania

Virginia Cornish, PhD, Columbia University

Yael David, PhD, Memorial Sloan Kettering Cancer Center

Christopher am Ende, PhD, Pfizer Inc.

Robert P. Fisher, MD, PhD, Mount Sinai School of Medicine

Kevin Gardner, PhD, CUNY Advanced Science Research Center

Catherine L. Grimes, PhD, University of Delaware

Akira Kawamura, PhD, CUNY – Hunter College

Jon Lai, PhD, Albert Einstein College of Medicine

Thomas Leyh, PhD, Albert Einstein College of Medicine

Tania Lupoli, PhD, New York University

Jin Kim Montclare, PhD, Polytechnic Institute of New York University

Allie Obermeyer, PhD, Columbia University

E. James Petersson, PhD, University of Pennsylvania

Deborah Rothman, PhD, Merck & Co Inc.

David Sabatino, PhD, Seton Hall University

Mohammad R. Seyedsayamdost, PhD, Princeton University

Neel H. Shah, PhD, Columbia University

Sarah Slavoff, PhD, Yale University

Derek S. Tan, PhD, Memorial Sloan Kettering Cancer Center

Ekaterina (Katya) Vinogradova, PhD, Rockefeller University

Neal J. Zondlo, PhD, University of Delaware

Machine Learning Discussion Group

Pattern recognition wizardry—from Siri to self-driving cars

The Machine Learning Discussion Group has held symposia for the better part of two decades to discuss advanced research related to such topics. Participants come from a variety of disciplines and from both academic and industry institutions, promoting the exchange of new insights between communities.

Machine Learning Steering Committee Members

Naoki Abe, PhD, IBM Research

Corinna Cortes, PhD, Google Research

Patrick Haffner, PhD, Amazon

Tony Jebara, PhD, Spotify

John Langford, PhD, Microsoft Research

Mehryar Mohri, PhD, Google Research

Alexander Rakhlin, PhD, MIT

Brooke Grindlinger, PhD, The New York Academy of Sciences

Melanie Brickman Borchard, PhD, MSc, The New York Academy of Sciences

Microbiology and Infectious Diseases Discussion Group

Preparing to fight tomorrow’s disease outbreaks, today

Our portfolio of events and publications in Microbiology and Infectious Diseases is designed to surface new discoveries and tackle current challenges in biomedical research and public health efforts to understand, treat, control, and prevent over 200 known infectious diseases. Beyond a better understanding of infectious disease etiology, epidemiology, diagnosis, and care, we also explore broader issues such as the roles that human demographics and behavior, international travel and commerce, technology and industry, economic development, microbial adaptation and change, and the breakdown of public health measures play in the complex coexistence of microbes and man.

Microbiology and Infectious Diseases Steering Committee Members

Annaliesa S. Anderson, PhD, Pfizer

Doris Bucher, PhD, New York Medical College

Nancy Connell, PhD, Rutgers New Jersey Medical School

Johanna P. Daily, MD, Albert Einstein College of Medicine

Matthew Evans, PhD, Icahn School of Medicine and Mount Sinai

Vincent Fischetti, PhD, The Rockefeller University

Allan Goldberg, PhD, Avacyn Pharmaceuticals, Inc.

Lorrence Green, PhD, Westbury Diagnostics, Inc

Takushi Kaneko, PhD, TB Alliance

Barry Kreiswirth, PhD, Rutgers New Jersey Medical School

W. Ian Lipkin, MD, Columbia University

Stephen Morse, PhD, Columbia University

Paul Offit, MD, Children’s Hospital of Philadelphia

David Perlin, PhD, Public Health Research Institute, New Jersey Medical School/ Rutgers Biomedical and Health Sciences

Shirley Raps, PhD, Hunter College, City University of New York

Yegor Voronin, PhD, Global HIV Vaccine Enterprise

Michael Watson, MD, Moderna Therapeutics

Science Unusual: Japan’s Earthquake Preparedness Culture: How Science Helps Minimize Disaster

Science Unusual Earthquake Prep

March 26, 2024 | 12:00 PM – 1:00 PM ET

This event is part of the International Science Reserve‘s Science Unusual webinar series.

There is hardly a nation on Earth that experiences more earthquakes than Japan. The country’s response to a 7.6 magnitude earthquake on January 1, 2024, demonstrated that advance preparation and investment across government, research institutions, industry, and local communities are key to saving lives and preventing severe damage. What are disaster researchers learning from Japan’s culture of preparedness to better reduce risk in other regions and countries?

Japan was not always known for seismic preparedness. The country learned hard lessons in the aftermath of a 1995 earthquake that struck near Kobe, resulting in the deaths of more than 6,000 people and knock-on effects leaving 300,000 people homeless. In the years since, a shift towards preparation has played a key role in mitigating major disasters.

By attending this live panel discussion, you will:

  • Learn about the role of science and engineering in the Japanese earthquake preparedness and response model;
  • Hear about scientific contributions to preparation efforts in Japan and around the globe;
  • Gain insights into different approaches – what has been effective and what has not;
  • Learn how scientists and policymakers can work together to mitigate future disasters.

Presented By

The logo for the International Science Reserve.

Innovations in AI and Higher Education, with Reid Hoffman and Nicholas B. Dirks

The cover for two books: City of Intellect: The Uses and Abuses of the University by Nicholas B. Dirks and Impromptu: Amplifying Our Humanity Through AI by Reid Hoffman with GPT-4.

March 27, 2024 | 6:00 PM – 7:00 PM ET

Join author Reid Hoffman and the Academy’s CEO Nicholas B. Dirks for a discussion about the potential of AI, especially the powerful Large Language Models like GPT-4, in shaping the future of education, business, and creativity—and Hoffman’s new book, Impromptu: Amplifying Our Humanity Through AI.

Through this interactive exploration, readers witness a compelling vision of the future, where AI becomes not a threat but a transformative partner, unlocking the full potential of humanity. Impromptu is an invitation to join the conversation on shaping our collaborative journey into an AI-powered destiny. Explore solutions, navigate uncertainties, and contribute to the evolving narrative of humanity’s partnership with GPT-4.

The discussion will also focus on the state of higher education in the US, in conjunction with the release of Nick Dirks’ newest book, City of Intellect: The Uses and Abuses of the University.

About the Author

Reid Hoffman is the co-founder of LinkedIn, co-founder of Inflection AI, and a partner at Greylock. He currently serves on the boards of companies such as Aurora, Coda, Convoy, Entrepreneur First, Joby, Microsoft, Nauto, and Neeva. He also serves on nonprofit boards, such as Kiva, Endeavor, CZI Biohub, New America, Berggruen Institute, Opportunity@Work, the Stanford Institute for Human-Centered AI, the MacArthur Foundation’s Lever for Change, and The New York Academy of Sciences.

He is the host of the podcasts Masters of Scale and Possible. He is the co-author of four best-selling books: The Startup of You, The Alliance, Blitzscaling, and Masters of Scale. He earned a master’s degree in philosophy from Oxford University, where he was a Marshall Scholar and a bachelor’s degree with distinction in symbolic systems from Stanford University.

Course: Pathways to Success: Effective Mentorship in STEM

An illustration with various abstract headshots.

April 9, 2024 | 1:00 – 2:00 PM ET

Mentorship is a collaborative learning relationship that benefits all participants. In fact, effective mentorship is a key factor contributing to a high rate of degree attainment, increased social and self awareness, sharper communication skills, career satisfaction, and other benefits that last for many years.

The New York Academy of Sciences is thrilled to partner with the National Research Mentoring Network (NRMN) to provide a free online webinar highlighting the potential and importance of effective mentorship in STEM. NRMN’s mission is to provide researchers across all career stages in the biomedical, behavioral, clinical, and social sciences with the evidence-based mentorship and professional development programming that emphasizes the benefits and challenges of diversity, inclusivity and culture. 

This event is tailored for individuals at all ages and professional levels looking to enrich their career through collaborating and learning from a mentor or mentee, and for anyone interested in sharing this information with their network. Join us and learn from experts in the field about how effective mentorship can benefit you and your community.

Speakers

Toufeeq Ahmed Syed, PhD, MS

Dr. Toufeeq Ahmed Syed is an Associate Professor and Assistant Dean of Education Informatics at the McWilliams School of Biomedical Informatics and McGovern Medical School, The University of Texas Health Science Center at Houston. Dr. Syed has over 15 years of experience developing national online platforms and portals and serves as (multiple) Principal Investigator of the NIH-funded AIM-AHEAD program (Artificial Intelligence/Machine Learning Consortium to Advance Health Equity and Researcher Diversity) and as Co-Investigator for National Research Mentoring Network (NRMN), Dr. Syed designed and developed MyNRMN (https://my.nrmnet.net), a powerful mentoring platform to support faculty, students, mentors, and mentees in building mentoring relationships and their professional networks. MyNRMN has over 8,300 mentors and 15,600 mentees in the platform and has facilitated over 12,000 mentoring connections (one-on-one, peer, near-peer, and group mentoring) for the NRMN community of mentors and mentees across all 50 states and from more than 4,100 institutions.

Marcus Lambert, PhD, MS

Dr. Marcus Lambert is the Associate Vice President of Research and an Associate Professor of Epidemiology and Biostatistics at SUNY Downstate Health Sciences University. His research group studies workforce diversity and mentorship in scientific training, with a particular interest in mentorship networks. Dr. Lambert has led and designed multiple mentor and mentee trainings for biomedical scientists, and co-leads several research training grants. Dr. Lambert received his Ph.D. in biomedical science from NYU Grossman School of Medicine, an M.S. in Clinical Epidemiology and Health Services Research from Weill Cornell Graduate School, and a B.S. from Howard University.

Ross Prize Symposium 2024: Cancer Neuroscience

An abstract scientific illustration.

The annual Ross Prize in Molecular Medicine is established in conjunction with the Feinstein Institutes for Medical Research and Molecular Medicine. The winner will be an active investigator having produced innovative, paradigm-shifting research that is worthy of significant and broad attention in the field of molecular medicine. We expect this individual will continue to garner recognition in future years, and that their current accomplishments reflect a rapidly rising career trajectory of discovery and invention. 

Expert Speaker Talk Lurie Prize Winners 2023 Presented by FNIH and The New York Academy of Sciences

An abstract graphic.

April 19, 2024 | 6:00 PM – 7:00 PM ET

Embark on an exhilarating journey into mitochondrial breakthroughs with 2023 Lurie Prize Winners, Drs. Chandel and Mootha. Uncover Dr. Chandel’s revelations on mitochondria as powerful influencers of our daily functions and disease and learn about Dr. Mootha’s, MitoCarta. Following the talk, participants are invited to dive into a Q+A session and connect with Drs. Chandel and Mootha directly. Register now for this thrilling night of cutting-edge science, discoveries, and insights.

Expert Talk with Dr. Anne Brunet and Dr. Andrew Dillin

Books on a bookshelf.

Participants will hear from Drs. Anne Brunet & Andrew Dillin selected as the winners of the tenth annual Lurie Prize in Biomedical Sciences, presented as part of the 2022 Foundation for the National Institutes of Health (FNIH) Awards Ceremony. In this talk, Drs. Brunet & Dillin will present on their complementary research on the cellular mechanics of aging, followed by an audience Q&A.

Frontiers in Immunology

A complicated scientific illustration.

Technological developments such as next-generation sequencing, super-resolution imaging, and systems-level computational approaches have resulted in great leaps in our understanding of the immune system. Despite these advances, many autoimmune diseases lack effective treatments; and the current pandemic has shown the critical need to better understand the immune system in order to harness it to develop vaccines and therapeutics.

Therapeutic Promise of the Microbiome: The Dr. Paul Janssen Award Symposium

An abstract scientific illustration.

Developing targeted therapies for rare cardiomyopathies is challenging: difficulties identifying patients, delivering therapeutics, and accessing heart tissue results in a 50% mortality rate 5 years after diagnosis.  Early, accurate disease detection and classification can significantly improve outcomes for patients with rare cardiomyopathies. Achieving these goals requires multiple novel technologies to coalesce that will enable early patient identification, deepen our understanding of the disease process, improve modeling of human pathophysiology, accelerate testing of drug candidates, and leverage novel therapeutic modalities to target the heart specifically, safely and effectively.

This two-day conference will convene industry scientists, academics, and clinicians to understand the integration of artificial intelligence and engineered tissues for safe and effective delivery of novel therapeutics for patients with arrhythmogenic, hypertrophic, and dilated cardiomyopathies.